These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2589233)

  • 1. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
    Pollera CF; Nardi M; Marolla P; Pinnaró P; Terzoli E; Giannarelli D
    Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study.
    Gez E; Warner-Efraty E; Ben-Yosef R; Ben-Baruch N; Yitzhaki N; Uziely B; Brufman G; Biran S
    Oncology; 1987; 44(4):237-9. PubMed ID: 3614813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose metoclopramide and dexamethasone as an antiemetic in chemotherapy of breast cancer.
    Gez E; Goodman S; Isacson R; Gerra C; Sulkes A
    Oncology; 1986; 43(3):173-5. PubMed ID: 3754627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study.
    Gez E; Sulkes A; Ochayon L; Gera C; Nathan S; Cass Y; Rubello E; Biran S
    J Chemother; 1989 Dec; 1(6):365-8. PubMed ID: 2693621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
    Strum SB; McDermed JE; Liponi DF
    J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
    Levitt M; Warr D; Yelle L; Rayner HL; Lofters WS; Perrault DJ; Wilson KS; Latreille J; Potvin M; Warner E
    N Engl J Med; 1993 Apr; 328(15):1081-4. PubMed ID: 8455665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
    Cognetti F; Pinnarò P; Carlini P; Conti EM; Cortese M; Pollera CF
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):183-7. PubMed ID: 6368241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
    Pollera CF; Nardi M; Marolla P; Carlini P
    Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of antiemetic use with CMF chemotherapy.
    Brown RS; Brown TK; Hoare D; Gaze MN
    Clin Oncol (R Coll Radiol); 1998; 10(5):313-7. PubMed ID: 9848332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiemetic efficacy of methylprednisolone compared with metoclopramide in outpatients receiving adjuvant CMF chemotherapy for breast cancer: a randomized trial.
    Campora E; Chiara S; Bruzzi P; Scarsi P; Rosso R
    Tumori; 1985 Oct; 71(5):459-62. PubMed ID: 3904102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study.
    Buser KS; Joss RA; Piquet D; Aapro MS; Cavalli F; Haefliger JM; Jungi WF; Bauer J; Obrist R; Brunner KW
    Ann Oncol; 1993 Jun; 4(6):475-9. PubMed ID: 8353089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study.
    Roila F; Basurto C; Minotti V; Ballatori E; Tonato M; Del Favero A
    Oncology; 1988; 45(5):346-9. PubMed ID: 3412741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
    Pollera CF; Nardi M; Marolla P; Calabresi F
    Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
    Niiranen A; Mattson K
    Am J Clin Oncol; 1987 Aug; 10(4):325-9. PubMed ID: 3039831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Grunberg SM; Akerley WL; Krailo MD; Johnson KB; Baker CR; Cariffe PA
    Cancer Invest; 1986; 4(5):379-85. PubMed ID: 3801953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
    Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].
    Domaradzka-Woźniak A; Wojtacki J; Dziewulska-Bokiniec A
    Przegl Lek; 1994; 51(5):203-5. PubMed ID: 7938648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone as antiemetic treatment in breast-cancer patients receiving cyclophosphamide, methotrexate, and 5-fluorouracil: a prospective, crossover, randomized blind study comparing two different dose schedules.
    Gez E; Strauss N; Vitzhaki N; Cass Y; Edelmann DZ
    Cancer Chemother Pharmacol; 1992; 30(3):229-32. PubMed ID: 1628373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.